School of Medicine

Wayne State University School of Medicine

Clinical Trials & Studies

Gilenya ®Imaging Study– Patients starting Gilenya® will have a unique MRI brain Scan performed. – Open to Enrollment
ASSESS – Study Comparing Two Doses of Fingolimod versus Copaxone ® In Patients with Relapsing Remitting Multiple Sclerosis. - Open To Enrollment
African-American Genetics Study –- One time blood collection- Opent to Enrollment
Vaccinex - Study comparing the safety and tolerability of VX 15/2503 in patient with Multiple Sclerosis - Closed to Enrollment
Oratorio: A Study Evaluating The Safety and Effectivness of Ocrelizumab vs Placebo in Patients With Primary Progressive MS - Closed To Enrollment
GA Azilect – Combination study with Copaxone ® and oral pill - Closed To Enrollment
OPERA: A Study Comparing The Treatment of Ocrelizumab to Rebif® In Patient With Relapsing MS - Closed To Enrollment
Acorda DER – Oral pill to improve muscle endurance and walking - Closed to Enrollment
Tysabri® Imaging Study– Patients starting Tysabri® will have a unique MRI brain Scan performed. – Closed to Enrollment
SURPASS- Study Evaluating the Benefits of Switching Current MS Therapy (Copaxone® or Rebif®) to Tysabri®- Closed to Enrollment
GALA- Study Evaluating Low-Frequency Administration of Copaxone ®- Closed to Enrollment
Fingolimod PPMS- Oral Pill Study Sponsored by Novartis for the Treatment of Primary Progressive Multiple Sclerosis – Closed to Enrollment
CAMPATH I – A yearly infusion or treatment with Rebif® in MS patients who are newly diagnosed- Closed to Enrollment
CAMPATH II – A yearly infusion or treatment with Rebif® in MS patients who have been on therapy- Closed to Enrollment
COMBI RX- The NIH sponsored study combining Copaxone® and Avonex® - Closed to Enrollment
Copaxone Long Term Open-Label (Copaxone®) – Long term safety and efficacy study with Copaxone®- Closed to Enrollment